Cancer News and Research

Latest Cancer News and Research

One-a-day tablet treats common infection

A bioadhesive tablet containing the antifungal drug miconazole is an effective and convenient means of treating oropharyngeal candidiasis, which is the most frequently occurring infection in head and neck cancer patients undergoing radiation therapy, scientists reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Test accurately predicts aggressiveness of breast cancer

A test that measures how quickly cells are dividing is an accurate way for doctors to predict the aggressiveness of breast cancer tumors, even among women with very early stages of the disease, researchers told the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Gene linked to lower breast cancer risk

In a presentation at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary, Dr. Uwe Langsenlehner and colleagues from Medical University Graz in Austria showed that a specific genetic variation in a cytokine gene is associated with lower breast cancer risk.

6 Jun 2005

New survey shows Americans falling short on sun protection

Over the past year, the number of Americans using sunscreen, a primary protector against skin cancer, has declined. At the same time, more Americans, including children, are being diagnosed with skin cancer than ever before.

6 Jun 2005

Study clarifies risk of recurrence for high-risk breast cancer patients

High-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unless their cancer has spread to more than 10 axillary lymph nodes, Italian researchers reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Chemotherapy options improve for patients with advanced colorectal cancer

For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC).

6 Jun 2005

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

A single injection of a genetically engineered virus has shown promise as a treatment for patients with colorectal cancer that has spread to the liver, according to preliminary results reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Scientists create digital bacteria to advance biomedical research

Scientists at the University of Chicago and Argonne National Laboratory have constructed a computer simulation that allows them to study the relationship between biochemical fluctuations within a single cell and the cell's behavior as it interacts with other cells and its environment.

5 Jun 2005

Vitamin B6 decreases risk of colorectal cancer

According to a study published in the American Gastroenterological Association (AGA) journal Gastroenterology, women with a high dietary intake of vitamin B6 over several years have a decreased risk of colorectal cancer (CRC).

5 Jun 2005

Discovery will lead to more effective treatments for pulmonary arterial hypertension

A University of Alberta research team has discovered important new information they hope will lead to more effective treatments for pulmonary arterial hypertension (PAH)--a deadly form of high blood pressure in the pulmonary arteries caused by uncontrolled cell growth.

5 Jun 2005

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.

5 Jun 2005

Link between childhood leukemia and power lines at the most, slight

In the on-going debate over whether proximity to high voltage power lines may be linked to childhood leukemia, researchers have found the association remains "slight" and "the relation may be due to chance."

5 Jun 2005

Toxic chemicals that poisoned your great-grandparents may also damage your health

New U.S. research is suggesting that chemicals can change the way genes work and that toxic chemicals that poisoned your great-grandparents may also damage your health.

5 Jun 2005

Oral cancer screening saves lives

Oral cancer is the 8th most common cancer in men and ranks 14th among women worldwide. There were 274,300 new cases and 145,500 deaths worldwide in 2002. Two-thirds of this burden are borne by developing countries, and over 30% by India alone. A high rate of oral cancer has been recorded in the Indian subcontinent, central and eastern Europe, parts of France, southern Europe, South America, and Oceania.

3 Jun 2005

Childhood cancer and distance from high-voltage power lines

UK Health Protection Agency response to British Medical Journal paper examining the incidence of childhood cancer in England and Wales and how it relates to distance from major high-voltage overhead power lines has been published.

3 Jun 2005

Childhood cancer in relation to distance from high voltage power lines - results may be entirely due to chance

Cancer Research UK comments on the BMJ paper "Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case control study."

3 Jun 2005

Introgen wins European patent decision on p53 gene therapeutic

Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.

3 Jun 2005

Exposure to aflatoxins that contaminate crops in developing countries can be reduced by a simple, cost-effective intervention

Exposure to a cancer-causing toxin that contaminates crops in developing countries can be reduced by a simple, cost-effective intervention on post-harvest storage, concludes a study in this week’s issue of The Lancet.

3 Jun 2005

Visually screening the mouths of individuals at high-risk of oral cancer could prevent around 37000 worldwide

Visually screening the mouths of individuals at high-risk of oral cancer could prevent around 37,000 worldwide deaths annually from the disease, suggests a study published in this week’s issue of The Lancet.

3 Jun 2005

Genetics may play a role in the effectiveness of chemotherapy drugs

Today, the most common childhood cancer is cured in about 80 percent of patients; only forty years ago, this number was closer to five percent. In efforts to further increase the survival rate, researchers from St. Jude Children's Research Hospital, the University of Tennessee, and the University of Chicago studied how an individual's genetics might play a role in the effectiveness of chemotherapy drugs.

3 Jun 2005